201 related articles for article (PubMed ID: 21585280)
21. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
[No Abstract] [Full Text] [Related]
22. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
[No Abstract] [Full Text] [Related]
23. The full spectrum of Castleman disease: 273 patients studied over 20 years.
Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
[TBL] [Abstract][Full Text] [Related]
24. Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
Cai S; Zhong Z; Li X; Wang HX; Wang L; Zhang M
Medicine (Baltimore); 2019 Nov; 98(46):e17681. PubMed ID: 31725610
[TBL] [Abstract][Full Text] [Related]
25. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.
Fajgenbaum DC
Blood; 2018 Nov; 132(22):2323-2330. PubMed ID: 30487129
[TBL] [Abstract][Full Text] [Related]
26. Treatment of multicentric Castleman’s disease in HIV-1 infected and uninfected patients: a systematic review.
Rokx C; Rijnders BJ; van Laar JA
Neth J Med; 2015 Jun; 73(5):202-10. PubMed ID: 26087799
[TBL] [Abstract][Full Text] [Related]
27. [Clinical Features and Prognosis of Patients with Castleman's Disease].
Huang XJ; Zhang XL; Wei XF; Liang XQ; Fu Y; Zhao YY; Li QF; Zhang QK; Feng YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):135-140. PubMed ID: 36765490
[TBL] [Abstract][Full Text] [Related]
28. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
[TBL] [Abstract][Full Text] [Related]
29. Castleman disease: Experience from a single institution.
Abraham SS; Narayanan G; Thambi SM; Vasudevan JA; Joy Philip DS; Purushothaman PN; Nair SG; Nair R
Med Int (Lond); 2023; 3(6):56. PubMed ID: 37927353
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
31. Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.
Pria AD; Pinato D; Roe J; Naresh K; Nelson M; Bower M
Blood; 2017 Apr; 129(15):2143-2147. PubMed ID: 28143881
[TBL] [Abstract][Full Text] [Related]
32. Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China.
Guo M; Nong L; Wang M; Zhang Y; Wang L; Sun Y; Wang Q; Liu H; Ou J; Cen X; Ren H; Dong Y
Ann Hematol; 2024 Jan; 103(1):153-162. PubMed ID: 37749319
[TBL] [Abstract][Full Text] [Related]
33. Overview of Castleman disease.
Dispenzieri A; Fajgenbaum DC
Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
[TBL] [Abstract][Full Text] [Related]
34. Castleman disease: A single-center case series.
Pribyl K; Vakayil V; Farooqi N; Arora N; Kreitz B; Ikramuddin S; Linden MA; Harmon J
Int J Surg Case Rep; 2021 Mar; 80():105650. PubMed ID: 33631648
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
Yu L; Tu M; Cortes J; Xu-Monette ZY; Miranda RN; Zhang J; Orlowski RZ; Neelapu S; Boddu PC; Akosile MA; Uldrick TS; Yarchoan R; Medeiros LJ; Li Y; Fajgenbaum DC; Young KH
Blood; 2017 Mar; 129(12):1658-1668. PubMed ID: 28100459
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment outcome of Castleman's disease: A real-world experience.
Min GJ; Jeon YW; Kim TY; Kwag DH; Lee JH; Lee JY; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
Front Oncol; 2022; 12():974770. PubMed ID: 35992883
[TBL] [Abstract][Full Text] [Related]
37. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
Fragasso A; Mannarella C; Ciancio A; Calvario A; Scarasciulli ML
Leuk Lymphoma; 2008 Nov; 49(11):2224-6. PubMed ID: 19021070
[No Abstract] [Full Text] [Related]
38. Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital.
González-García A; Patier de la Peña JL; García-Cosio M; Sarhane Y; Sánchez Díaz C; Barbolla Díaz I; López Rodríguez M; Moreno MÁ; Villarubia J; Manzano L
Leuk Lymphoma; 2019 Dec; 60(14):3442-3448. PubMed ID: 31305183
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of 65 patients with Castleman disease in a single center in China.
Wang XQ; Zhong NN; Sun Q; Yan SC; Xu GC; Wang YG; Peng LW; Liu B; Bu LL
Sci Rep; 2022 May; 12(1):8694. PubMed ID: 35610300
[TBL] [Abstract][Full Text] [Related]
40. Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases.
Nagao A; Nakazawa S; Hanabusa H
J Hematol Oncol; 2014 Jan; 7():10. PubMed ID: 24438824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
